Sign in
CompletedNo phase

Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

Key facts

Who runs it
Global Stem Cell Center, Baghdad
Where
Iraq1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
8 Feb 2022
Ended
16 Jan 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • autologous bone marrow aspirate concentrate by centrifugation
Record updated
17 January 2024

Who can take part

Age
55 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Radiological diagnosis of Osteoarthritis according to Kellgren and Lawrence Criteria stage II-III; Radiological grading of osteoarthritis of the knee determined by qualified radiologist using MOAKS scoring system; Primary osteoarthritis not responsive to conventional treatment and physiotherapy; A minimum pain score of 5 on an 11-point numerical scale; Age >55 years

Who cannot take part

  • Previous knee surgery within the last 12 months
  • Previous intra-articular injectable therapies within the last 6 months
  • Knee symptom due to other condition like tumor or referred pain from lumbar spine
  • History of severe systemic illness
  • Active neoplasm under treatment in the last 12 months- Health conditions including known allergy to local
  • Bleeding tendency
  • Pregnancy and breast feeding
  • MRI confirmed displaced meniscal tear
  • MRI confirmed Grade IV chondral loss

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

We present a randomized controlled trial (RCT) to assess the efficacy of autologous bone marrow aspirate concentrate BMAC of 1.8x 10 9 median cellular content in the treatment of early symptomatic knee OA. We use 2 injections 2 months apart (8).

The 2 groups in the trial

  • treatment with autologous bone marrow aspirate concentrateExisting treatment, for comparison

    autologous bone marrow aspirate is taken under local anesthesia to be centrifuged and the concentrate given intra articularly in knee joint

    Treatment: autologous bone marrow aspirate concentrate by centrifugation

  • controlSham treatment, for comparison

    control group given analgesics only

    Treatment: autologous bone marrow aspirate concentrate by centrifugation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Ibn-Sina Hospital, Baghdad 2022
Record updated
17 January 2024